Moderna Interest Income vs Operating Income Analysis

MRNA Stock

USD 125.59 14.13 12.68%

Moderna financial indicator trend analysis is infinitely more than just investigating Moderna recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Moderna is a good investment. Please check the relationship between Moderna Interest Income and its Operating Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.

Interest Income vs Operating Income

Interest Income vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Moderna Interest Income account and Operating Income. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Moderna's Interest Income and Operating Income is -0.26. Overlapping area represents the amount of variation of Interest Income that can explain the historical movement of Operating Income in the same time period over historical financial statements of Moderna, assuming nothing else is changed. The correlation between historical values of Moderna's Interest Income and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Income of Moderna are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Interest Income i.e., Moderna's Interest Income and Operating Income go up and down completely randomly.

Correlation Coefficient

-0.26

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Operating Income

Operating Income is the amount of profit realized from Moderna operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Moderna is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from Moderna's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Moderna current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.At present, Moderna's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 1.2 B, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.19.

	2021	2022	2023	2024 (projected)
Interest Income	18M	200M	405M	425.3M
Net Interest Income	18M	200M	363M	381.2M

Interest Income Net Interest Income

Moderna fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Net Receivables	Other Current Assets	Total Liab	Deferred Long Term Liab	Total Current Assets	Intangible Assets	Common Stock	Other Current Liab	Common Stock Shares Outstanding	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments
Total Assets		0.86	0.99	0.91	0.93	0.93	0.92	0.87	0.84	0.38	0.91	-0.47	0.95	0.74	-0.98	0.98	0.7	0.95	0.89	0.64	-0.81	0.93	0.78	0.8	0.66	0.92
Total Current Liabilities	0.86		0.77	0.65	0.65	0.64	0.61	0.99	0.99	0.14	0.99	-0.14	0.96	0.63	-0.78	0.8	0.66	0.69	0.59	0.94	-0.98	0.74	0.42	0.92	0.55	0.97
Total Stockholder Equity	0.99	0.77		0.93	0.96	0.98	0.96	0.79	0.74	0.45	0.83	-0.54	0.89	0.73	-0.98	0.98	0.66	0.98	0.94	0.51	-0.71	0.95	0.86	0.71	0.65	0.85
Other Liab	0.91	0.65	0.93		0.95	0.91	0.96	0.69	0.64	0.32	0.72	-0.69	0.79	0.7	-0.92	0.92	0.76	0.95	0.95	0.38	-0.61	0.83	0.78	0.62	0.71	0.74
Net Tangible Assets	0.93	0.65	0.96	0.95		0.96	0.99	0.69	0.64	0.34	0.71	-0.73	0.79	0.75	-0.96	0.95	0.6	1.0	1.0	0.37	-0.61	0.87	0.84	0.62	0.67	0.76
Retained Earnings	0.93	0.64	0.98	0.91	0.96		0.98	0.66	0.61	0.47	0.71	-0.6	0.79	0.62	-0.97	0.96	0.55	0.97	0.95	0.34	-0.56	0.94	0.91	0.6	0.55	0.75
Accounts Payable	0.92	0.61	0.96	0.96	0.99	0.98		0.65	0.6	0.37	0.68	-0.73	0.76	0.7	-0.95	0.94	0.59	0.99	0.99	0.31	-0.56	0.87	0.87	0.58	0.65	0.72
Cash	0.87	0.99	0.79	0.69	0.69	0.66	0.65		0.99	0.13	0.99	-0.19	0.97	0.67	-0.81	0.83	0.65	0.73	0.63	0.91	-0.98	0.75	0.41	0.95	0.6	0.99
Net Receivables	0.84	0.99	0.74	0.64	0.64	0.61	0.6	0.99		0.08	0.98	-0.17	0.94	0.62	-0.77	0.79	0.64	0.68	0.58	0.94	-0.99	0.7	0.36	0.95	0.54	0.97
Other Current Assets	0.38	0.14	0.45	0.32	0.34	0.47	0.37	0.13	0.08		0.21	0.04	0.3	0.33	-0.39	0.37	0.31	0.37	0.33	-0.05	-0.02	0.55	0.54	0.09	0.26	0.21
Total Liab	0.91	0.99	0.83	0.72	0.71	0.71	0.68	0.99	0.98	0.21		-0.18	0.98	0.66	-0.83	0.85	0.7	0.76	0.66	0.9	-0.96	0.81	0.5	0.91	0.6	0.98
Deferred Long Term Liab	-0.47	-0.14	-0.54	-0.69	-0.73	-0.6	-0.73	-0.19	-0.17	0.04	-0.18		-0.23	-0.5	0.55	-0.55	-0.29	-0.69	-0.77	0.09	0.17	-0.31	-0.51	-0.17	-0.41	-0.25
Total Current Assets	0.95	0.96	0.89	0.79	0.79	0.79	0.76	0.97	0.94	0.3	0.98	-0.23		0.7	-0.9	0.9	0.71	0.82	0.74	0.81	-0.91	0.89	0.6	0.89	0.65	0.98
Intangible Assets	0.74	0.63	0.73	0.7	0.75	0.62	0.7	0.67	0.62	0.33	0.66	-0.5	0.7		-0.68	0.68	0.59	0.75	0.74	0.48	-0.63	0.61	0.51	0.51	0.84	0.65
Common Stock	-0.98	-0.78	-0.98	-0.92	-0.96	-0.97	-0.95	-0.81	-0.77	-0.39	-0.83	0.55	-0.9	-0.68		-1.0	-0.62	-0.97	-0.93	-0.52	0.74	-0.93	-0.79	-0.78	-0.62	-0.88
Other Current Liab	0.98	0.8	0.98	0.92	0.95	0.96	0.94	0.83	0.79	0.37	0.85	-0.55	0.9	0.68	-1.0		0.62	0.97	0.92	0.55	-0.76	0.91	0.77	0.8	0.61	0.89
Common Stock Shares Outstanding	0.7	0.66	0.66	0.76	0.6	0.55	0.59	0.65	0.64	0.31	0.7	-0.29	0.71	0.59	-0.62	0.62		0.64	0.59	0.54	-0.6	0.6	0.45	0.54	0.73	0.64
Short Long Term Debt Total	0.95	0.69	0.98	0.95	1.0	0.97	0.99	0.73	0.68	0.37	0.76	-0.69	0.82	0.75	-0.97	0.97	0.64		0.99	0.42	-0.65	0.89	0.84	0.65	0.68	0.79
Property Plant And Equipment Net	0.89	0.59	0.94	0.95	1.0	0.95	0.99	0.63	0.58	0.33	0.66	-0.77	0.74	0.74	-0.93	0.92	0.59	0.99		0.3	-0.55	0.83	0.84	0.55	0.68	0.7
Current Deferred Revenue	0.64	0.94	0.51	0.38	0.37	0.34	0.31	0.91	0.94	-0.05	0.9	0.09	0.81	0.48	-0.52	0.55	0.54	0.42	0.3		-0.94	0.49	0.12	0.85	0.38	0.85
Net Debt	-0.81	-0.98	-0.71	-0.61	-0.61	-0.56	-0.56	-0.98	-0.99	-0.02	-0.96	0.17	-0.91	-0.63	0.74	-0.76	-0.6	-0.65	-0.55	-0.94		-0.64	-0.3	-0.95	-0.53	-0.96
Non Current Assets Total	0.93	0.74	0.95	0.83	0.87	0.94	0.87	0.75	0.7	0.55	0.81	-0.31	0.89	0.61	-0.93	0.91	0.6	0.89	0.83	0.49	-0.64		0.87	0.66	0.59	0.82
Non Currrent Assets Other	0.78	0.42	0.86	0.78	0.84	0.91	0.87	0.41	0.36	0.54	0.5	-0.51	0.6	0.51	-0.79	0.77	0.45	0.84	0.84	0.12	-0.3	0.87		0.28	0.47	0.5
Other Assets	0.8	0.92	0.71	0.62	0.62	0.6	0.58	0.95	0.95	0.09	0.91	-0.17	0.89	0.51	-0.78	0.8	0.54	0.65	0.55	0.85	-0.95	0.66	0.28		0.46	0.96
Long Term Debt	0.66	0.55	0.65	0.71	0.67	0.55	0.65	0.6	0.54	0.26	0.6	-0.41	0.65	0.84	-0.62	0.61	0.73	0.68	0.68	0.38	-0.53	0.59	0.47	0.46		0.58
Cash And Short Term Investments	0.92	0.97	0.85	0.74	0.76	0.75	0.72	0.99	0.97	0.21	0.98	-0.25	0.98	0.65	-0.88	0.89	0.64	0.79	0.7	0.85	-0.96	0.82	0.5	0.96	0.58

Click cells to compare fundamentals

Moderna Account Relationship Matchups

Moderna fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.6B	7.3B	24.7B	25.9B	18.4B	19.3B
Total Current Liabilities	143.1M	4.4B	9.1B	4.9B	3.0B	2.4B
Total Stockholder Equity	1.2B	2.6B	14.1B	19.1B	13.9B	14.5B
Other Liab	139.1M	179.3M	691M	808M	929.2M	975.7M
Net Tangible Assets	1.2B	2.6B	14.1B	19.1B	22.0B	23.1B
Retained Earnings	(1.5B)	(2.2B)	10.0B	18.3B	13.6B	14.3B
Accounts Payable	7.1M	18.4M	302M	487M	520M	546M
Cash	235.9M	2.6B	6.8B	3.2B	2.9B	1.8B
Net Receivables	16.3M	1.4B	3.3B	1.4B	1.1B	886.7M
Other Current Assets	887.9M	(405.6M)	55M	1.2B	88M	83.6M
Total Liab	414.6M	4.8B	10.5B	6.7B	4.6B	3.1B
Total Current Assets	1.3B	6.3B	17.6B	13.4B	10.3B	5.8B
Common Stock	33K	34K	40K	(857M)	(771.3M)	(732.7M)
Other Current Liab	5.1M	33.7M	2.4B	2.2B	1.9B	2.0B
Common Stock Shares Outstanding	330.8M	381.3M	431M	416M	382M	346.5M
Short Long Term Debt Total	132.4M	207.3M	916M	1.2B	1.2B	1.3B
Property Plant And Equipment Net	287.9M	387.1M	1.4B	2.1B	2.7B	2.8B
Current Deferred Revenue	63.3M	3.9B	6.3B	2.0B	568M	539.6M
Net Debt	(103.5M)	(2.4B)	(5.9B)	(2.0B)	(1.7B)	(1.7B)
Non Current Assets Total	326.4M	1.0B	7.1B	12.4B	8.1B	4.1B
Non Currrent Assets Other	(121.5M)	12.9M	46M	988M	523M	549.2M
Other Assets	12.7M	742.0M	7.4B	1.9B	2.2B	1.6B
Cash And Short Term Investments	1.3B	5.2B	17.6B	9.9B	8.6B	6.3B
Short Term Investments	867.1M	2.0B	3.9B	6.7B	5.7B	3.0B
Liabilities And Stockholders Equity	1.6B	7.3B	24.7B	25.9B	18.4B	11.3B
Non Current Liabilities Total	271.5M	386.6M	1.4B	1.8B	1.6B	868.0M
Capital Surpluse	2.7B	4.8B	4.2B	1.2B	1.3B	2.4B
Capital Lease Obligations	132.4M	207.3M	916M	1.0B	1.2B	1.3B
Other Stockholder Equity	2.7B	4.8B	4.2B	1.2B	371M	352.5M
Long Term Investments	160.0M	638.8M	6.8B	8.3B	4.7B	2.9B
Accumulated Other Comprehensive Income	1.8M	3.0M	(24M)	(370M)	(123M)	(116.9M)
Non Current Liabilities Other	138K	386.6M	1.4B	135M	256M	299.3M
Short Term Debt	67.7M	469.6M	211M	196M	25M	23.8M
Property Plant Equipment	287.9M	387.1M	1.4B	2.1B	2.5B	2.6B
Net Invested Capital	1.2B	2.6B	14.1B	19.1B	13.9B	8.1B
Property Plant And Equipment Gross	287.9M	387.1M	1.7B	2.1B	3.1B	3.2B

Moderna Investors Sentiment

The influence of Moderna's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Moderna. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Moderna's public news can be used to forecast risks associated with an investment in Moderna. The trend in average sentiment can be used to explain how an investor holding Moderna can time the market purely based on public headlines and social activities around Moderna. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Moderna's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Moderna's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Moderna's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Moderna.

Moderna Implied Volatility

107.64

Moderna's implied volatility exposes the market's sentiment of Moderna stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Moderna's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Moderna stock will not fluctuate a lot when Moderna's options are near their expiration.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Moderna in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Moderna's short interest history, or implied volatility extrapolated from Moderna options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:

How To Invest In Moderna

Details

Is Moderna Stock a good investment?

Details

What is Moderna's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Moderna Stock analysis

When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.

	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Transaction History View history of all your transactions and understand their impact on performance
	CEOs Directory Screen CEOs from public companies around the world
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk

Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.85)

Earnings Share

(12.33)

Revenue Per Share

17.927

Quarterly Revenue Growth

(0.45)

Return On Assets

(0.12)

The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moderna is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Moderna Interest Income vs Operating Income Analysis

Interest Income vs Operating Income

Interest Income vs Operating Income Correlation Analysis

Correlation Coefficient

Interest Income

Operating Income

Moderna fundamental ratios Correlations

Moderna Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Moderna fundamental ratios Accounts

Moderna Investors Sentiment

Moderna Implied Volatility

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Moderna Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Long Term Debt Total	+ 1.0	Net Tangible Assets
Property Plant And Equipment Net	+ 1.0	Net Tangible Assets
Total Stockholder Equity	+ 0.99	Total Assets
Cash	+ 0.99	Total Current Liabilities
Net Receivables	+ 0.99	Total Current Liabilities
Total Liab	+ 0.99	Total Current Liabilities

Other Current Liab	- 1.0	Common Stock
Net Debt	- 0.99	Net Receivables
Net Debt	- 0.98	Cash
Common Stock	- 0.98	Total Stockholder Equity
Net Debt	- 0.98	Total Current Liabilities
Common Stock	- 0.98	Total Assets